| Literature DB >> 35295572 |
Carlos Hernando1,2, Carla Hernando3, Nayara Panizo4, Eladio Collado-Boira5, Ana Folch-Ayora5, Ignacio Martínez-Navarro6,7, Barbara Hernando8.
Abstract
Long distance races have a physiological impact on runners. Up to now, studies analyzing these physiological repercussions have been mainly focused on muscle and cardiac damage, as well as on its recovery. Therefore, a limited number of studies have been done to explore acute kidney failure and recovery after performing extreme exercises. Here, we monitored renal function in 76 marathon finishers (14 females) from the day before participating in a marathon until 192 h after crossing the finish line (FL). Renal function was evaluated by measuring serum creatinine (sCr) and the glomerular filtration rate (GFR). We randomly grouped our cohort into three intervention groups to compare three different strategies for marathon recovery: total rest (REST), continuous running at their ventilatory threshold 1 (VT1) intensity (RUN), and elliptical workout at their VT1 intensity (ELLIPTICAL). Interventions in the RUN and ELLIPTICAL groups were performed at 48, 96, and 144 h after marathon running. Seven blood samples (at the day before the marathon, at the FL, and at 24, 48, 96, 144, and 192 h post-marathon) and three urine samples (at the day before the marathon, at the finish line, and at 48 h post-marathon) were collected per participant. Both heart rate monitors and triaxial accelerometers were used to control the intensity effort during both the marathon race and the recovery period. Contrary to our expectations, the use of elliptical machines for marathon recovery delays renal function recovery. Specifically, the ELLIPTICAL group showed a significantly lower ∆GFR compared to both the RUN group (p = 4.5 × 10-4) and the REST group (p = 0.003). Hence, we encourage runners to carry out an active recovery based on light-intensity continuous running from 48 h after finishing the marathon. In addition, full resting seems to be a better strategy than performing elliptical workouts.Entities:
Keywords: active recovery; acute kidney injury; glomerular filtration rate; marathon; passive recovery
Year: 2022 PMID: 35295572 PMCID: PMC8918951 DOI: 10.3389/fphys.2022.812237
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Description of study cohort.
| Variable | RUN | ELLIPTICAL | REST | |
|---|---|---|---|---|
| Physiological characteristics | Age | 38.73 ± 3.92 | 37.86 ± 3.72 | 38.94 ± 3.26 |
| BMI | 22.71 ± 1.27 | 23.49 ± 2.05 | 22.73 ± 1.74 | |
| % body fat | 14.74 ± 3.25 | 13.81 ± 3.67 | 19.54 ± 4.16 | |
| Weight | 67.88 ± 7.87 | 72.77 ± 10.86 | 71.03 ± 8.93 | |
| Height | 171.32 ± 8.47 | 173.73 ± 9.75 | 174.91 ± 7.84 | |
| V·O2max (ml·kg−1·min−1) | 55.08 ± 6.04 | 53.96 ± 5.42 | 54.06 ± 6.21 | |
| VT1 (ml·kg−1·min−1) | 38.75 ± 3.80 | 38.48 ± 4.71 | 37.11 ± 4.45 | |
| VT2 (ml·kg−1·min−1) | 46.54 ± 4.35 | 45.87 ± 4.91 | 45.06 ± 4.49 | |
| Training indicators | Sessions per week | 4.73 ± 1.08 | 5.05 ± 0.67 | 4.84 ± 0.81 |
| Kilometers per week | 61.82 ± 14.27 | 63.33 ± 11.33 | 65.16 ± 12.21 | |
| Hours per week | 7.00 ± 2.74 | 7.83 ± 2.90 | 7.36 ± 2.00 | |
| History as marathoner | Marathons finished | 3.41 ± 2.94 | 3.29 ± 3.02 | 2.69 ± 2.40 |
| Marathon per year | 1.36 ± 0.90 | 1.14 ± 0.48 | 0.91 ± 0.39 | |
| Work intensity | High intensity | 4.50% | 13.60% | 6.30% |
| Medium intensity | 40.90% | 18.20% | 34.40% | |
| Low intensity | 54.50% | 68.20% | 59.40% | |
| Levels of study | School graduate | 4.50% | 4.80% | 6.30% |
| High school graduate | 4.50% | 4.80% | 9.40% | |
| Professional certificate | 13.60% | 23.80% | 15.60% | |
| Undergraduate degree | 77.30% | 66.70% | 68.80% | |
N, number of samples; F, female; BMI, body mass index; SD, standard deviation; V·O2max, maximal oxygen consumption; and VT, ventilatory threshold.
Values are presented as mean ± SD.
Values are presented as percentage of all individuals.
Comparison of data collected prior to intervention.
| Variable | RUN | ELLIPTICAL | REST |
|
|---|---|---|---|---|
| Marathon time (min) | 213.59 ± 20.24 | 216.40 ± 19.63 | 215.85 ± 21.87 | 0.869 |
| Absence AKI at the finish line | 11 (50%) | 9 (40.9%) | 17 (53.1%) | 0.341 |
| Presence AKI at the finish line | 11 (50%) | 11 (50%) | 15 (46.9%) | |
| Grade 1 at the finish line | 10 (45.5%) | 10 (45.5%) | 15 (46.9%) | |
| Grade 2 at the finish line | 1 (4.5%) | 1 (4.5%) | 0 (0.0%) | |
| Presence of hematuria at the finish line | 9 (40.9%) | 8 (36.4%) | 11 (34.4%) | 0.886 |
| Presence of hematuria 48 h after marathon | 0 (0%) | 1 (4.5%) | 2 (6.3%) | 0.503 |
N, number of subjects; F, female; AKI, acute kidney injury; and p, p-value. Data is presented as mean ± SD for continuous variables, and sample size (percentage) for categorical variables.
ANOVA Levene test.
Chi Square test.
Evolution of serum creatinine (sCr) and the glomerular filtration rate (GFR) in the three groups during the whole study.
| Start line (1st time point) | Finish Line (2nd time point) | 24 h post (3rd time point) | 48 h post (4th time point) | 96 h post (5th time point) | 144 h post (6th time point) | 192 h post (7th time point) | Friedmann | |
|---|---|---|---|---|---|---|---|---|
| Serum creatinine (mg/dl) | ||||||||
| RUN | 1.00 [0.88–1.10]2,6 | 1.34 [1.15–1.49]1,3,4,5,6,7 | 0.90 [0,80-1,03]2,4 | 1.00 [0.90–1.10]2,3,5,6,7 | 0.90 [0.80–1.03]2,4 | 0.90 [0.80–1.00]1,2,4 | 0.90 [0.80–1.00]2,4 |
|
| 0.90 [0.80–1.00]2,4 | 1.26 [1.15–1.36]1,3,4,5,6,7 | 0.90 [0.85–1.00]2,4 | 1.00 [0,90–1.10]1,2,3,7 | 1.00 [0.80–1.10]2 | 0.90 [0.88–1.10]2 | 0.90 [0.80–1.00]2,4 |
| |
| REST | 0.90 [0.80–1.08]2,6 | 1.31 [1.13–1.44]1,3,4,5,6,7 | 0.90 [0.80–1.00]2 | 1.00 [0.90–1.10]2,6,7 | 0.90 [0.80–1.08]2 | 0.90 [0.80–1.00]1,2,4 | 0.90 [0.80–1.00]2,4 |
|
| Kruskal-Wallis | 0.448 | 0.712 | 0.832 | 0.526 | 0.534 | 0.183 | 0.996 | |
| Glomerular filtration rate (ml/min/1.73 m2) | ||||||||
| RUN | 72.91 [66.24–99.25]2,6 | 51.69 [44.17–61.03]1,3,4,5,6,7 | 94.64 [67.95–104.22]2,4 | 69.91 [62.95–90.27]2,3,5,6,7 | 95.69 [68.06–102.92]2,4 | 100,46 [73.30–105.26]1,2,4 | 98.06 [73.30–104.44]2,4 |
|
| 94.92 [71.65–100.50]2,4 | 54.60 [48.93–61.16]1,3,4,5,6,7 | 81.37 [68.93–98.76]2,4 | 69.41 [63.84–92.19]1,2,3 | 69.90 [61.53–101.20]2 | 80.52 [63.84–101.74]2 | 97.03 [69.17–105.12]2 |
| |
| REST | 85.87 [66.54–97.88]2,6 | 51.10 [45.85–61.74]1,3,4,5,6,7 | 94.62 [69.29–102.74]2 | 71.90 [63.62–97.06]2,6,7 | 95.25 [64.72–100.62]2 | 97.37 [72.53–104.01]1,2,4 | 95.58 [72.15–102.02]2,4 |
|
| Kruskal-Wallis | 0.415 | 0.704 | 0.759 | 0.636 | 0.514 | 0.168 | 0.695 | |
Data is presented as median and interquartile range (IQR). Values of blood biomarkers in finish line (FL) were adjusted according to the method of Dill and Costill (1974). GFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation (Levey et al., 2009). N, number of participants; F, female; and p, p-value.
Significant differences between the different time points where data was collected after applying Bonferroni correction method. Bold font indicates statistical significance across all time points after applying Bonferroni correction method.
Blood samples from two participants (one female) included in the ELLIPTICAL group were not collected in the FL (2nd time point) because of logistic problems.
Figure 1Evolution of glomerular filtration rate relative to baseline (∆GFR) in the three groups during the whole study. (A) REST group. (B) ELLIPTICAL group. (C) RUNNING group. SL, start line; and FL, finish line.
Figure 2Comparison of ∆GFR between the tree groups during the intervention phase of the study. (A) After 48 h from the first intervention (at 96 h post-marathon). (B) After 48 h from the second intervention (at 144 h post-marathon). (C) After 48 h from the third intervention (at 192 h post-marathon). Re, participants included in the REST group (green-rimmed boxes); E, participants included in the ELLIPTICAL group (orange-filled boxes); and Ru, participants included in the RUN group (blue-dashed boxes).
Figure 3Comparison of energy consumption (kcal/kg/min) between the three groups during the intervention phase of the study. (A) Energy consumed by each group during the three 8-h segments where the recovery activity was performed (24 h in total). (B) Energy consumed by each group during the time of the intervention phase where runners are not performing the activity (13 8-h segments). Re, participants included in the REST group (green-rimmed boxes); E, participants included in the ELLIPTICAL group (orange-filled boxes); and Ru, participants included in the RUN group (blue-dashed boxes).